Registered number
10338501
MQS PHARM LTD
Filleted Accounts
31 August 2024
MQS PHARM LTD
Registered number: 10338501
Balance Sheet
as at 31 August 2024
Notes 2024 2023
£ £
Fixed assets
Tangible assets 3 435 586
Current assets
Debtors 4 9,963 10,731
Cash at bank and in hand 57,179 39,260
67,142 49,991
Creditors: amounts falling due within one year 5 (11,960) (9,686)
Net current assets 55,182 40,305
Total assets less current liabilities 55,617 40,891
Creditors: amounts falling due after more than one year 6 (6,220) (4,610)
Net assets 49,397 36,281
Capital and reserves
Called up share capital 50 50
Profit and loss account 49,347 36,231
Shareholder's funds 49,397 36,281
The director is satisfied that the company is entitled to exemption from the requirement to obtain an audit under section 477 of the Companies Act 2006.
The member has not required the company to obtain an audit in accordance with section 476 of the Act.
The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.
The accounts have been prepared and delivered in accordance with the special provisions applicable to companies subject to the small companies regime. The profit and loss account has not been delivered to the Registrar of Companies.
MOHAMMAD QASIM SADIQ
Director
Approved by the board on 5 November 2024
MQS PHARM LTD
Notes to the Accounts
for the year ended 31 August 2024
1 Accounting policies
Basis of preparation
The accounts have been prepared under the historical cost convention and in accordance with FRS 102, The Financial Reporting Standard applicable in the UK and Republic of Ireland (as applied to small entities by section 1A of the standard).
Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services. Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have transferred to the buyer. Turnover from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs.
Tangible fixed assets
Tangible fixed assets are measured at cost less accumulative depreciation and any accumulative impairment losses. Depreciation is provided on all tangible fixed assets, other than freehold land, at rates calculated to write off the cost, less estimated residual value, of each asset evenly over its expected useful life, as follows:
Plant and machinery over 10 years
Debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2 Employees 2024 2023
Number Number
Average number of persons employed by the company 1 1
3 Tangible fixed assets
Plant and machinery
£
Cost
At 1 September 2023 1,512
At 31 August 2024 1,512
Depreciation
At 1 September 2023 926
Charge for the year 151
At 31 August 2024 1,077
Net book value
At 31 August 2024 435
At 31 August 2023 586
4 Debtors 2024 2023
£ £
Trade debtors 9,963 10,731
5 Creditors: amounts falling due within one year 2024 2023
£ £
Taxation and social security costs 7,327 7,657
Other creditors 4,633 2,029
11,960 9,686
6 Creditors: amounts falling due after one year 2024 2023
£ £
Directors Loan 6,220 4,610
7 Other information
MQS PHARM LTD is a private company limited by shares and incorporated in England. Its registered office is:
112 YEWS HILL ROAD
HUDDERSFIELD
HD1 3SG
MQS PHARM LTD 10338501 false 2023-09-01 2024-08-31 2024-08-31 VT Final Accounts July 2024 MOHAMMAD QASIM SADIQ No description of principal activity 10338501 2022-09-01 2023-08-31 10338501 core:WithinOneYear 2023-08-31 10338501 core:AfterOneYear 2023-08-31 10338501 core:ShareCapital 2023-08-31 10338501 core:RetainedEarningsAccumulatedLosses 2023-08-31 10338501 2023-09-01 2024-08-31 10338501 bus:PrivateLimitedCompanyLtd 2023-09-01 2024-08-31 10338501 bus:AuditExempt-NoAccountantsReport 2023-09-01 2024-08-31 10338501 bus:Director40 2023-09-01 2024-08-31 10338501 1 2023-09-01 2024-08-31 10338501 core:PlantMachinery 2023-09-01 2024-08-31 10338501 countries:England 2023-09-01 2024-08-31 10338501 bus:FRS102 2023-09-01 2024-08-31 10338501 bus:FilletedAccounts 2023-09-01 2024-08-31 10338501 2024-08-31 10338501 core:WithinOneYear 2024-08-31 10338501 core:AfterOneYear 2024-08-31 10338501 core:ShareCapital 2024-08-31 10338501 core:RetainedEarningsAccumulatedLosses 2024-08-31 10338501 core:PlantMachinery 2024-08-31 10338501 2023-08-31 10338501 core:PlantMachinery 2023-08-31 iso4217:GBP xbrli:pure